These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28905291)

  • 1. Morphology effect of nano-hydroxyapatite as a drug carrier of methotrexate.
    Sun H; Liu S; Zeng X; Meng X; Zhao L; Wan Y; Zuo G
    J Mater Sci Mater Med; 2017 Sep; 28(10):158. PubMed ID: 28905291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self assembly and controlled drug release of a nano-laminated graphite carbon nitride/methotrexate complex.
    Liu S; Guo Z; Zeng X; Meng X; Sun H; Wan Y; Zuo G
    J Mater Sci Mater Med; 2018 Jul; 29(8):116. PubMed ID: 30027359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile synthesis of methotrexate intercalated layered double hydroxides: particle control, structure and bioassay explore.
    Tian DY; Liu ZL; Li SP; Li XD
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():297-305. PubMed ID: 25491832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of nanostructured methotrexate/hydroxyapatite: Morphology control, growth mechanism, and bioassay explore.
    Dai CF; Li SP; Li XD
    Colloids Surf B Biointerfaces; 2015 Dec; 136():262-71. PubMed ID: 26409253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyapatite-chitosan biocomposites synthesized in the simulated body fluid and their drug loading studies.
    Basargan T; Erdol-Aydin N; Nasun-Saygili G
    J Mater Sci Mater Med; 2017 Oct; 28(11):180. PubMed ID: 28986683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Fe3O4/HAp Magnetically Nanoparticles as the Carrier for Ibuprofen: Adsorption and Release Study.
    Mohammadi-Aghdam S; Valinezhad-Saghezi B; Mortazavi Y; Qhoreishi SM
    Drug Res (Stuttg); 2019 Feb; 69(2):93-99. PubMed ID: 29996174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
    Prabha G; Raj V
    Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydroxyapatite particle size, morphology and crystallinity on proliferation of colon cancer HCT116 cells.
    Dey S; Das M; Balla VK
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():336-9. PubMed ID: 24863233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green synthesis of Si-incorporated hydroxyapatite using sodium metasilicate as silicon precursor and in vitro antibiotic release studies.
    Abinaya Sindu P; Kolanthai E; Suganthi RV; Thanigai Arul K; Manikandan E; Catalani LH; Narayana Kalkura S
    J Photochem Photobiol B; 2017 Oct; 175():163-172. PubMed ID: 28888169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ biomimetic synthesis and characterization of nano hydroxyapatite in gelatin matrix.
    Sadjadi MA; Meskinfam M; Sadeghi B; Jazdarreh H; Zare K
    J Biomed Nanotechnol; 2011 Jun; 7(3):450-4. PubMed ID: 21830488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
    Yang P; Quan Z; Li C; Kang X; Lian H; Lin J
    Biomaterials; 2008 Nov; 29(32):4341-7. PubMed ID: 18715638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction-degradable PEG-b-PAA-b-PEG triblock copolymer micelles incorporated with MTX for cancer chemotherapy.
    Sun Y; Huang Y; Bian S; Liang J; Fan Y; Zhang X
    Colloids Surf B Biointerfaces; 2013 Dec; 112():197-203. PubMed ID: 23981981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Optimization of PEGylated Nano Graphene Oxide-Based Delivery System for Drugs with Different Molecular Structures Using Design of Experiment (DoE).
    Shariare MH; Masum AA; Alshehri S; Alanazi FK; Uddin J; Kazi M
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyapatite nanocrystals: simple preparation, characterization and formation mechanism.
    Mohandes F; Salavati-Niasari M; Fathi M; Fereshteh Z
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():29-36. PubMed ID: 25491798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTX/LDHs hybrids synthesized from reverse microemulsions: particle control and bioassay study.
    Liu ZL; Tian DY; Li SP; Li XD; Lu TH
    Int J Pharm; 2014 Oct; 473(1-2):414-25. PubMed ID: 25089502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and biocompatibility of nanohybrid scaffold prepared via in situ crystallization of hydroxyapatite in chitosan matrix.
    Chen J; Nan K; Yin S; Wang Y; Wu T; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):640-7. PubMed ID: 20817419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
    Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
    Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.
    Ignjatović NL; Penov-Gaši KM; Ajduković JJ; Kojić VV; Marković SB; Uskoković DP
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():371-377. PubMed ID: 29752109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.